Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Trends Pharmacol Sci. 2019 Feb 28;40(4):253–266. doi: 10.1016/j.tips.2019.02.004

Table 2.

Examples of atheroprotective drugs that target MSTFs

Name of drug Effect on
atherosclerosis
Targeted MSTFs References
Statins (+) KLF2; (+) KLF4; (+) NRF2; (−) NF-κB; (−) AP1; (−) YAP/TEAD; (−) HIF-1α [26, 27, 66, 67, 99-102]
Resveratrol (+) KLF2; (+) KLF4; (+) NRF2; (−) NF-κB [22, 68, 69, 103, 104]
Tannic acid (+) KLF2 [71, 72]
SAHA (+) KLF2 [70]
Sulforaphane (+) NRF2; (−) NF-κB [75, 105]
Verteporfin (−) YAP/TEAD [77, 78]
Evodiamine (−) HIF-1α [79, 106]
Digoxin (−) HIF-1α [80, 81]
2-Methoxyestradiol (−) HIF-1α [82, 83]

(+) activate; (−) inhibit.